News ArticleMax Healthcare Approves Q2 2026 Financial Results and Major Expansion Projects in Noida and Vaishali
Company sanctions ~₹190 Crore for hospital expansions and revises Gurugram hospital project cost to ~₹1,143 Crore with April 2027 completion target
Max Healthcare Institute Limited approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company also sanctioned capital expenditure of approximately ₹93 Crore for expanding Max Super Speciality Hospital in Noida and ₹97 Crore for additional floors at Max Super Speciality Hospital in Vaishali, alongside revising the Gurugram hospital project's cost to ₹1,143 Crore with a completion timeline set for April 2027.
Max Healthcare Institute Limited
General / Other
Max Healthcare Institute Limited has approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The Board also approved capital expenditure plans totaling approximately ₹190 Crore to expand its hospitals in Noida and Vaishali, and revised the Gurugram hospital project cost and timeline.
The Board sanctioned about ₹93 Crore for redevelopment and clinical capacity enhancement at Max Super Speciality Hospital in Sector-128, Noida, operated by its wholly-owned subsidiary Crosslay Remedies Limited.
Approximately ₹97 Crore was approved for constructing additional floors over the existing tower at Max Super Speciality Hospital, Vaishali, also operated by Crosslay.
In continuation of earlier disclosures, the Board approved revising the estimated project cost of the ~525 bedded hospital in Sector-56, Gurugram to around ₹1,143 Crore. The expected completion date for this project is April 2027, with cost increases attributed to changes in façade specifications, construction requirements, and interior enhancements.
The Board approved the appointment of Dr. Dharmender Kumar as Director & Chief Public Affairs, a senior management position, effective November 1, 2026.
Highlights
- Unaudited standalone and consolidated financial results approved for quarter and half year ending September 30, 2026.
- ₹93 Crore capital expenditure approved for Max Super Speciality Hospital Noida expansion.
- ₹97 Crore capital expenditure approved for additional floors at Max Super Speciality Hospital Vaishali.
- Gurugram hospital project cost revised to approximately ₹1,143 Crore with April 2027 completion date.
- Dr. Dharmender Kumar appointed as Director & Chief Public Affairs from November 1, 2026.
Key Data Snapshot
What happened
- Max Healthcare Institute Limited approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
- The Board sanctioned capital expenditures for expansion of Max Super Speciality Hospitals in Noida and Vaishali, totaling approximately ₹190 Crore.
- The project cost for the ~525 bedded hospital in Gurugram was revised to approximately ₹1,143 Crore with a planned completion in April 2027.
- Dr. Dharmender Kumar was appointed as Director & Chief Public Affairs, a senior management role, effective November 1, 2026.
Key details
- Max Super Speciality Hospital in Noida expansion includes redevelopment and clinical capacity enhancement.
- Max Super Speciality Hospital in Vaishali will have additional floors constructed over the existing tower.
- Gurugram hospital cost increase is mainly due to façade specification changes, additional construction, atrium development, and enhanced interior fit-outs.
- The Gurugram hospital project timeline revision does not impact other project aspects except cost and schedule.
Regulatory and governance context
- Financial results were approved based on the Audit Committee recommendation.
- Limited review reports by M/s. S.R. Batliboi & Co. LLP, Statutory Auditors, were unmodified.
- Capital expenditure approvals and appointments are disclosed in line with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Highlights
- Unaudited standalone and consolidated financial results approved for quarter and half year ending September 30, 2026.
- ₹93 Crore capital expenditure approved for Max Super Speciality Hospital Noida expansion.
- ₹97 Crore capital expenditure approved for additional floors at Max Super Speciality Hospital Vaishali.
- Gurugram hospital project cost revised to approximately ₹1,143 Crore with April 2027 completion date.
- Dr. Dharmender Kumar appointed as Director & Chief Public Affairs from November 1, 2026.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Source Information
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
GAIL (India) Limited Reports ₹11,611.44 Crore Profit Before Tax for Q2 and H1 FY2026-27
GAIL (India) Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, recording ₹11,611.44 crore profit before tax for the half year and total income of ₹86,116.52 crore.
Read Full Story
Max Healthcare Q2 FY27 Revenue Rises 20% to ₹3,219 Crore; PAT Increases 10% to ₹448 Crore
Max Healthcare Institute Limited reported a 20% year-on-year increase in gross revenue to ₹3,219 crore for the second quarter ended September 30, 2026, alongside a 10% rise in profit after tax to ₹448 crore. Operational bed capacity expanded by 16% year-on-year to 5,518 beds, supporting increased patient service volume.
Read Full Story
GAIL Extends Completion Date for Gurdaspur-Jammu Pipeline Project to December 2026
GAIL has extended the completion schedule for the Gurdaspur-Jammu Pipeline Project to December 2026 due to delays in obtaining forest permissions in Punjab, with 153 km of the 160 km pipeline completed and 78 km commissioned so far, without requiring additional investment.
Read Full Story
